|
|
Næsseslottet , Dronninggaards Allé 136
Holte, DK 2840 Denmark
phone:+ (45) 45 47 50 00 00
fax:+ (45) 45 47 50 01
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.actionpharma.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Drugs primarily for cardiovascular diseases. |
|
| Management |
| Prof. Søren Nielsen, MD, DMSci. ( Co-founder ), CEO; Dr Thomas Jonassen, MD ( Co-founder ), CSO; Jeppe Øvli Øvlesen, EE, MBA, CFO & Vice President Business development; Dr. Karin Søgaard Madsen, VP, Clinical Development, Medical Director; Lene Gerlach, VP, IPR & Legal Affairs; Thomas Boesen, VP, Discovery & Early preclinical Development |
| |
|
|
| |
|
| Keywords |
| biopharmaceutical, laboratories, drugs, cardiovascular, copd, g-protein, cytokine, inflammation, renal, dermatitis |
|
|
|
| Description |
|
Action Pharma is dedicated to the discovery and development of novel drugs with significant therapeutic improvement within inadequately treated cardiovascular diseases. The company pursues the discovery and development of new drugs and treatment concepts within cardiovascular diseases associated with ischemia and inflammation. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members